
51 - 200 employés
Fondée en 2016
🏥 Santé
💼 Conseil
⚖️ Juridique
Healthcare • Consulting • Legal
Immunic Therapeutics est une entreprise de biotechnologie en phase avancée, spécialisée dans le développement de thérapies novatrices à petites molécules administrées par voie orale pour les maladies inflammatoires chroniques et auto-immunes, avec des programmes ciblant particulièrement la sclérose en plaques et la maladie cœliaque. L'entreprise fait progresser des programmes cliniques différenciés (par exemple, vidofludimus calcium, IMU-856, IMU-381) visant à fournir des options de traitement orales efficaces, sûres et bien tolérées pour les affections neurologiques et gastro-intestinales à médiation immune, tout en poursuivant des protections réglementaires et des voies de commercialisation.
🕒 il y a 9 jours
🗣️🇺🇸🇬🇧 Anglais requis
Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

51 - 200 employés
Fondée en 2016
🏥 Santé
💼 Conseil
⚖️ Juridique
Healthcare • Consulting • Legal
Immunic Therapeutics est une entreprise de biotechnologie en phase avancée, spécialisée dans le développement de thérapies novatrices à petites molécules administrées par voie orale pour les maladies inflammatoires chroniques et auto-immunes, avec des programmes ciblant particulièrement la sclérose en plaques et la maladie cœliaque. L'entreprise fait progresser des programmes cliniques différenciés (par exemple, vidofludimus calcium, IMU-856, IMU-381) visant à fournir des options de traitement orales efficaces, sûres et bien tolérées pour les affections neurologiques et gastro-intestinales à médiation immune, tout en poursuivant des protections réglementaires et des voies de commercialisation.
• Lead U.S. Market Access strategy and organization build for vidofludimus calcium's launch, covering pricing, contracting, reimbursement, and distribution • Develop integrated access strategies spanning Commercial, Medicare, Medicaid, VA, DoD, and other government channels • Own national payer strategy, negotiating with health plans, PBMs, IDNs, health systems, and specialty pharmacies • Build payer value propositions using clinical, economic, and real-world evidence to drive favorable formulary coverage • Set pricing strategy, gross-to-net assumptions, and specialty pharmacy/trade/distribution frameworks, ensuring launch-ready operations • Partner with Medical Affairs/HEOR on payer evidence strategy, AMCP dossiers, and value communication; support post-launch evidence generation • Serve on Commercial Leadership Team, coordinating with Marketing, Sales, Medical, Regulatory, Finance, Legal, and Supply Chain on launch readiness • Design and build the Market Access org structure, capabilities, and metrics across Payer Strategy, Marketing, Pricing/Contracting, Trade, Analytics, and Excellence functions • Recruit and lead a field Market Access team: National, Federal, and Regional Account Managers plus Field Reimbursement Managers • Set field deployment strategy (territories, hiring, training, incentives) and ensure tight collaboration with Sales and Medical Affairs to maximize adoption
• Bachelor's degree required; MBA, PharmD, MPH, or other advanced degree preferred. • 15+ years of progressive leadership experience within the pharmaceutical or biotechnology industry. • Demonstrated success leading U.S. Market Access organizations for specialty pharmaceutical products. • Direct experience leading the U.S. Market Access strategy for one or more multiple sclerosis product launches is strongly preferred. • Candidates who have played a significant leadership role in the commercialization of successful MS therapies will be strongly favored. • Deep understanding of the competitive dynamics, payer landscape, specialty pharmacy networks, treatment centers, and reimbursement environment within multiple sclerosis as well as negotiating with commercial payers, PBMs, Medicare Part D plans, federal healthcare systems, specialty pharmacies, and integrated health systems. • Demonstrated success building and leading field-based Market Access organizations; experience building commercial infrastructure within an emerging biotechnology company or first-launch organization strongly preferred.
• Health insurance • 401(k) • Paid time off • Flexible working arrangements • Professional development opportunities
Postuler Maintenant🕒 il y a 9 jours
Group Vice President leading a team to drive operational excellence and strategic growth in veterinary healthcare. Overseeing P&L performance and fostering a collaborative team culture.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 9 jours
Group Vice President leading a team of Regional Operations Directors to enhance veterinary medicine and hospital performance. Responsible for strategic growth, operational excellence, and people-first leadership.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 9 jours
VP of Marketing leading Ditto's marketing strategy and execution, a company redefining data connectivity. Collaborating with sales and product teams to build brand awareness and drive pipeline.
🇺🇸 États-Unis – Télétravail
💵 $288 000 - $300 000 / an
⏰ Temps Plein
🔴 Expert
👔 Vice-président
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 9 jours
Vice President, Corporate Development leading healthcare M&A and strategic partnerships for Sellers Dorsey, a healthcare impact strategy firm. Driving inorganic growth and overseeing the full M&A lifecycle.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 9 jours
Regional Vice President of Sales driving new revenue opportunities and managing relationships in managed vision care sector. Overseeing client partnerships and achieving targeted profitability with a focus on growth.
🗣️🇺🇸🇬🇧 Anglais requis